Financial incentives for breast cancer screening undermine informed choice

BMJ. 2022 Jan 10:376:e065726. doi: 10.1136/bmj-2021-065726.

Authors

Theodore Bartholomew¹, Mirela Colleoni², Harald Schmidt³

Affiliations

¹ Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
² Hauts-de-France, France.
³ Department of Medical Ethics and Health Policy, University of Pennsylvania, USA.

PMID: 35012959
DOI: 10.1136/bmj-2021-065726

No abstract available

MeSH terms

Breast Neoplasms / diagnosis
Breast Neoplasms / economics*
Early Detection of Cancer / economics*
Female
Humans
Mass Screening / economics*
Medical Overuse / economics*
Motivation*
Reimbursement, Incentive
United Kingdom